RE:RE:RE:New Press Release - ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer's DiseaseMy conjecture is it will be in 2-3 months, when 1a trial is completed, thus clearing the deck for an offering. At that point the stock should have built a good base at a slightly higher level than now. Don't assume that an offering would be at lower levels. There could be a 10x demand for the stock which drives the price up, like an IPO. The Boston group will put in $10M or possibly more and own 50%+ of Promis. Offering size of $20-30M. This is all conjecture on my part.